Healthcare M&A and Valuation
News and Insights

On May 28, 2025, global alternative asset manager Brookfield Asset Management, alongside Caisse de dépôt et placement du Québec (CDPQ), announced the acquisition  of GTCR’s Antylia Scientific, a U.S.-based integrated provider of scientific research tools, laboratory services and specialty instruments serving biopharma, diagnostics and academic markets. Antylia’s platform combines branded products, custom solutions, and technical services that address complex laboratory needs

The infusion therapy market has experienced significant growth in recent years, driven by the increasing prevalence of chronic diseases,...

The addiction treatment industry is a vital and rapidly evolving segment of the behavioral healthcare market, focused on the diagnosis...